Search

everythinglearnresearchcommunity

for

Search:↓

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

A woman's skin symptoms led to a diagnosis of systemic AL amyloidosis, but she died from sepsis shortly after.

Erianin may effectively treat alopecia areata by targeting the immune system.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Controlling Tslp can improve health in AEC syndrome patients.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Fetal skin biopsy can help diagnose protein-related disorders before birth.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Dupilumab helped a 13-year-old regrow hair after alopecia totalis.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Acitretin can cause eyebrow and eyelash hair loss.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Baricitinib is a safe and effective treatment for severe alopecia areata.

The serum with microneedling device improves hair loss treatment effectively and safely.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

New medications could improve treatment for severe alopecia areata in Australia.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Alopecia areata involves immune response and gene changes affecting hair loss.